The many “Neurofaces” of Prohibitins 1 and 2: Crucial for the Healthy Brain, Dysregulated in Numerous Brain Disorders

[1]  T. Tarragó,et al.  Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia , 2023, International journal of molecular sciences.

[2]  I. Matsui,et al.  Higher‐order structure formation using refined monomer structures of lipid raft markers, Stomatin, Prohibitin, Flotillin, and HflK/C‐related proteins , 2023, FEBS open bio.

[3]  Hanluo Li,et al.  EV-A71 Mechanism of Entry: Receptors/Co-Receptors, Related Pathways and Inhibitors , 2023, Viruses.

[4]  Á. Almeida,et al.  Cross-talk between energy and redox metabolism in astrocyte-neuron functional cooperation , 2023, Essays in biochemistry.

[5]  Hao Li,et al.  Pharmaceutical and pharmacological studies of Shen Ma Yi Zhi granule for prevention of vascular dementia: A review , 2022, Frontiers in Neuroscience.

[6]  N. Kadam,et al.  Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome. , 2022, Mitochondrion.

[7]  Jesus Fernandez-Abascal,et al.  Prohibitins in neurodegeneration and mitochondrial homeostasis , 2022, Frontiers in Aging.

[8]  Lihi Shaulov,et al.  SIAH proteins regulate the degradation and intra‐mitochondrial aggregation of PINK1: Implications for mitochondrial pathology in Parkinson's disease , 2022, Aging cell.

[9]  D. Thal,et al.  The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death , 2022, Brain Research Bulletin.

[10]  I. Ferrer.  Hypothesis review: Alzheimer's overture guidelines , 2022, Brain pathology.

[11]  H. Cao,et al.  Ketogenic Diet Alleviates Hippocampal Neurodegeneration Possibly via ASIC1a and the Mitochondria-Mediated Apoptotic Pathway in a Rat Model of Temporal Lobe Epilepsy , 2022, Neuropsychiatric disease and treatment.

[12]  A. Schwarz,et al.  Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease , 2022, Science Translational Medicine.

[13]  C. Xie,et al.  Microglia activation linking amyloid-β drive tau spatial propagation in Alzheimer's disease , 2022, Frontiers in Neuroscience.

[14]  Tianlin Jiang,et al.  Prohibitins: A Key Link between Mitochondria and Nervous System Diseases , 2022, Oxidative medicine and cellular longevity.

[15]  G. Logroscino,et al.  The Role of Graph Theory in Evaluating Brain Network Alterations in Frontotemporal Dementia , 2022, Frontiers in Neurology.

[16]  T. Wai,et al.  CHCHD10 and SLP2 control the stability of the PHB complex: a key factor for motor neuron viability. , 2022, Brain : a journal of neurology.

[17]  M. Venkataswamy,et al.  Infection of human microglial cell line CHME-3 to study neuropathogenesis of chikungunya virus , 2022, Journal of NeuroVirology.

[18]  F. Hollis,et al.  Neuroinflammation and Mitochondrial Dysfunction Link Social Stress to Depression. , 2022, Current topics in behavioral neurosciences.

[19]  D. Walker,et al.  Role of Prohibitins in Aging and Therapeutic Potential Against Age-Related Diseases , 2021, Frontiers in Genetics.

[20]  A. Adamczyk,et al.  The Role of Maternal Immune Activation in the Pathogenesis of Autism: A Review of the Evidence, Proposed Mechanisms and Implications for Treatment , 2021, International journal of molecular sciences.

[21]  E. R. Wilson,et al.  Activation of mTORC1 and c-Jun by Prohibitin1 loss in Schwann cells may link mitochondrial dysfunction to demyelination , 2021, eLife.

[22]  A. Baranova,et al.  Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping , 2021, Cells.

[23]  Xuemin Zhang,et al.  Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance , 2021, Nature Communications.

[24]  O. Keskin,et al.  Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins’ Mimicry of Human Protein Interactions , 2021, Frontiers in Human Neuroscience.

[25]  T. Hartung,et al.  C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly. , 2021, Cell metabolism.

[26]  Lei Wu,et al.  PHB blocks endoplasmic reticulum stress and apoptosis induced by MPTP/MPP+ in PD models , 2021, Journal of Chemical Neuroanatomy.

[27]  E. Ruiz-Pesini,et al.  Down syndrome is an oxidative phosphorylation disorder , 2021, Redox biology.

[28]  K. Palikaras,et al.  Neuronal Mitophagy: Friend or Foe? , 2021, Frontiers in Cell and Developmental Biology.

[29]  Bin Han,et al.  Genetic and non-genetic factors associated with the phenotype of exceptional longevity & normal cognition , 2020, Scientific Reports.

[30]  T. Tarragó,et al.  P.587 Prohibitin 2 study in postmortem prefrontal cortex in schizophrenia , 2020, European Neuropsychopharmacology.

[31]  E. R. Wilson,et al.  Prohibitin 1 is essential to preserve mitochondria and myelin integrity in Schwann cells , 2020, Nature Communications.

[32]  J. Baumbach,et al.  Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis , 2020, Network and systems medicine.

[33]  Zhenghong Qin,et al.  BNIP3L/NIX degradation leads to mitophagy deficiency in ischemic brains , 2020, Autophagy.

[34]  A. Desai,et al.  Prohibitin 1/2 mediates Dengue-3 entry into human neuroblastoma (SH-SY5Y) and microglia (CHME-3) cells , 2020, Journal of Biomedical Science.

[35]  C. Iadecola,et al.  Prohibitin S-Nitrosylation Is Required for the Neuroprotective Effect of Nitric Oxide in Neuronal Cultures , 2020, The Journal of Neuroscience.

[36]  K. Rajalingam,et al.  Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases , 2020, Cellular and Molecular Life Sciences.

[37]  M. Okun,et al.  Diagnosis and Treatment of Parkinson Disease: A Review. , 2020, JAMA.

[38]  J. Inal,et al.  Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines , 2020, International journal of molecular sciences.

[39]  Y. Hérault,et al.  A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment , 2020, Scientific Reports.

[40]  A. Kentsis,et al.  Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma. , 2019, JCI insight.

[41]  John H. Zhang,et al.  Mitophagy Reduces Oxidative Stress Via Keap1 (Kelch-Like Epichlorohydrin-Associated Protein 1)/Nrf2 (Nuclear Factor-E2-Related Factor 2)/PHB2 (Prohibitin 2) Pathway After Subarachnoid Hemorrhage in Rats , 2019, Stroke.

[42]  Domenico de Rasmo,et al.  Prohibitins: A Critical Role in Mitochondrial Functions and Implication in Diseases , 2019, Cells.

[43]  Jimmy D Bell,et al.  Cannabidiol Affects Extracellular Vesicle Release , miR 21 and miR 126 , and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells 1 , 2 , 2018 .

[44]  J. Inal,et al.  Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme , 2018, International journal of molecular sciences.

[45]  I. Jericó,et al.  Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) , 2018, International journal of molecular sciences.

[46]  J. Mann,et al.  Depression , 2018, The Lancet.

[47]  Bo Li,et al.  Brain microvascular endothelial cell exosome–mediated S100A16 up‐regulation confers small‐cell lung cancer cell survival in brain , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  Paul J. Harrison,et al.  The neuropathology of bipolar disorder: systematic review and meta-analysis , 2018, Molecular Psychiatry.

[49]  S. Tenzer,et al.  Targeting prohibitins at the cell surface prevents Th17‐mediated autoimmunity , 2018, The EMBO journal.

[50]  N. Cairns,et al.  TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics , 2018, Neuroscience Letters.

[51]  I. Scheffer,et al.  Epilepsy , 2018, Nature Reviews Disease Primers.

[52]  D. Patterson,et al.  Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model , 2018, Neurobiology of Aging.

[53]  K. Chung,et al.  New insight into transglutaminase 2 and link to neurodegenerative diseases , 2018, BMB reports.

[54]  J. Chu,et al.  Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis , 2018, PLoS pathogens.

[55]  Sudharsana Rao Ande,et al.  Prohibitin: a potential therapeutic target in tyrosine kinase signaling , 2017, Signal Transduction and Targeted Therapy.

[56]  U. Mony,et al.  Significance of elevated Prohibitin 1 levels in Multiple Sclerosis patients lymphocytes towards the assessment of subclinical disease activity and its role in the central nervous system pathology of disease. , 2017, International journal of biological macromolecules.

[57]  I. Ferrer,et al.  Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression , 2017, Scientific Reports.

[58]  H. Voss,et al.  Neuronal expression of the mitochondrial protein prohibitin confers profound neuroprotection in a mouse model of focal cerebral ischemia , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[59]  D. Geschwind,et al.  ASD Restricted and Repetitive Behaviors Associated at 17q21.33: Genes Prioritized by Expression in Fetal Brains , 2017, Molecular Psychiatry.

[60]  D. Klionsky,et al.  PHB2/prohibitin 2: An inner membrane mitophagy receptor , 2017, Cell Research.

[61]  Yangling Mu,et al.  Intense Exercise Promotes Adult Hippocampal Neurogenesis But Not Spatial Discrimination , 2017, Front. Cell. Neurosci..

[62]  J. Savitz,et al.  Neuropathology of mood disorders: do we see the stigmata of inflammation? , 2016, Translational psychiatry.

[63]  R. Kalaria.  Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease , 2016, Acta Neuropathologica.

[64]  E. Rugarli,et al.  Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria. , 2016, The Journal of cell biology.

[65]  T. Lim,et al.  F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy. , 2015, Human molecular genetics.

[66]  Artur B. Lourenço,et al.  Analysis of the effect of the mitochondrial prohibitin complex, a context-dependent modulator of longevity, on the C. elegans metabolome☆ , 2015, Biochimica et biophysica acta.

[67]  D. Butterfield,et al.  Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease , 2015, Journal of neurochemistry.

[68]  W. Blalock,et al.  Prohibitin 2: At a communications crossroads , 2015, IUBMB life.

[69]  B. Bogerts,et al.  Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy , 2015, Schizophrenia Research.

[70]  P. Guest,et al.  A targeted multiplexed proteomic investigation identifies ketamine-induced changes in immune markers in rat serum and expression changes in protein kinases/phosphatases in rat brain. , 2015, Journal of proteome research.

[71]  C. Iadecola,et al.  Prohibitin Viral Gene Transfer Protects Hippocampal CA1 Neurons From Ischemia and Ameliorates Postischemic Hippocampal Dysfunction , 2014, Stroke.

[72]  Y. Tan,et al.  Expression of PHB2 in Rat Brain Cortex Following Traumatic Brain Injury , 2014, International journal of molecular sciences.

[73]  B. O’Malley,et al.  Gonadotropin-releasing hormone-regulated prohibitin mediates apoptosis of the gonadotrope cells. , 2013, Molecular endocrinology.

[74]  Qing Xu,et al.  MicroRNA‐26a Promotes Tumor Growth and Angiogenesis in Glioma by Directly Targeting Prohibitin , 2013, CNS neuroscience & therapeutics.

[75]  N. Ribeiro,et al.  Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential , 2013, Chemistry & Biology.

[76]  P. Auewarakul,et al.  Identification of prohibitin as a Chikungunya virus receptor protein , 2012, Journal of medical virology.

[77]  E. Rugarli,et al.  Loss of Prohibitin Membrane Scaffolds Impairs Mitochondrial Architecture and Leads to Tau Hyperphosphorylation and Neurodegeneration , 2012, PLoS genetics.

[78]  M. Leippe,et al.  The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2. , 2012, Chemistry & biology.

[79]  P. Greengard,et al.  Small‐molecule inducers of Aβ‐42 peptide production share a common mechanism of action , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[80]  B. Bogerts,et al.  Increased Density of Prohibitin-Immunoreactive Oligodendrocytes in the Dorsolateral Prefrontal White Matter of Subjects with Schizophrenia Suggests Extraneuronal Roles for the Protein in the Disease , 2012, NeuroMolecular Medicine.

[81]  F. Nicoletti,et al.  Proteomic characterization in the hippocampus of prenatally stressed rats. , 2012, Journal of proteomics.

[82]  L. Carboni,et al.  Proteomics of rat hypothalamus, hippocampus and pre-frontal/frontal cortex after central administration of the neuropeptide PACAP , 2012, Molecular Biology Reports.

[83]  G. Wang,et al.  Prohibitin Reduces Mitochondrial Free Radical Production and Protects Brain Cells from Different Injury Modalities , 2012, The Journal of Neuroscience.

[84]  G. Upadhyay,et al.  Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation-dependent and -independent regulations. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[85]  T. Serikawa,et al.  Oligodendroglial pathology in the development of myelin breakdown in the dmy mutant rat , 2011, Brain Research.

[86]  Fiona E. N. LeBeau,et al.  Partial loss of parvalbumin‐containing hippocampal interneurons in dementia with Lewy bodies , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.

[87]  D. Dickson,et al.  TDP-43 in aging and Alzheimer's disease - a review. , 2011, International journal of clinical and experimental pathology.

[88]  Martina Schneider,et al.  Prohibitin1 acts as a neural crest specifier in Xenopus development by repressing the transcription factor E2F1 , 2010, Development.

[89]  M. Piacentini,et al.  Type 2 transglutaminase in Huntington’s disease: a double‐edged sword with clinical potential , 2010, Journal of internal medicine.

[90]  Sudharsana Rao Ande,et al.  The role of prohibitin in cell signaling , 2010, The FEBS journal.

[91]  Y. Oh,et al.  Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model , 2010, Neurochemistry International.

[92]  P. Joyce,et al.  Proteomic analysis of rat hippocampus exposed to the antidepressant paroxetine , 2010, Journal of psychopharmacology.

[93]  J. Mcculloch,et al.  Glioma Pathophysiology: Insights Emerging from Proteomics , 2010, Brain pathology.

[94]  B. Bogerts,et al.  Increased Oligodendroglial Expression of the Cell Proliferation-Controlling Protein Prohibitin in Schizophrenia. A Hint for Cell Cycle Abnormalities? , 2010 .

[95]  Yu-Ting Wu,et al.  Mitochondrial DNA Mutation-Elicited Oxidative Stress, Oxidative Damage, and Altered Gene Expression in Cultured Cells of Patients with MERRF Syndrome , 2010, Molecular Neurobiology.

[96]  Y. Mechref,et al.  Differential expression of proteins in fetal brains of alcohol‐treated prenatally C57BL/6 mice: A proteomic investigation , 2010, Electrophoresis.

[97]  P. Falkai,et al.  Proteome analysis of schizophrenia brain tissue , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[98]  John R. Yates,et al.  Severe Acute Respiratory Syndrome Coronavirus Nonstructural Protein 2 Interacts with a Host Protein Complex Involved in Mitochondrial Biogenesis and Intracellular Signaling , 2009, Journal of Virology.

[99]  R. Wenthold,et al.  NMDA receptors interact with flotillin‐1 and ‐2, lipid raft‐associated proteins , 2009, FEBS letters.

[100]  S. Robbins,et al.  Distinct Regions within the Erlins Are Required for Oligomerization and Association with High Molecular Weight Complexes* , 2009, Journal of Biological Chemistry.

[101]  H. Handa,et al.  Capsaicin binds to prohibitin 2 and displaces it from the mitochondria to the nucleus. , 2009, Biochemical and biophysical research communications.

[102]  B. Bogerts,et al.  A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia , 2008, Molecular Psychiatry.

[103]  I. Ferrer,et al.  Dystrophic neurites of senile plaques in Alzheimer’s disease are deficient in cytochrome c oxidase , 2008, Acta Neuropathologica.

[104]  Benedikt Westermann,et al.  Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. , 2008, Genes & development.

[105]  P. Joyce,et al.  Proteomic analysis of embryonic stem cell–derived neural cells exposed to the antidepressant paroxetine , 2008, Journal of neuroscience research.

[106]  M. Skalicky,et al.  Hippocampal signaling cascades are modulated in voluntary and treadmill exercise rats , 2007, Electrophoresis.

[107]  M. Barrachina,et al.  Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease , 2007, Neuroscience Letters.

[108]  Mauro Piacentini,et al.  Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders , 2007, Journal of neurochemistry.

[109]  Y. Kagawa,et al.  Mitochondrial Functions and Estrogen Receptor-dependent Nuclear Translocation of Pleiotropic Human Prohibitin 2* , 2006, Journal of Biological Chemistry.

[110]  Kyla Pennington,et al.  Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes , 2006, Proteomics.

[111]  T. Fahrig,et al.  A Synthetic Derivative of the Natural Product Rocaglaol Is a Potent Inhibitor of Cytokine-Mediated Signaling and Shows Neuroprotective Activity in Vitro and in Animal Models of Parkinson's Disease and Traumatic Brain Injury , 2005, Molecular Pharmacology.

[112]  Vani Santosh,et al.  Differential protein expression in human gliomas and molecular insights , 2005, Proteomics.

[113]  S. Chellappan,et al.  A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis. , 2003, Biochemical and biophysical research communications.

[114]  Ting-kai Li,et al.  Innate differences in protein expression in the nucleus accumbens and hippocampus of inbred alcohol‐preferring and ‐nonpreferring rats , 2003, Proteomics.

[115]  V. Pickel,et al.  Identification of a novel membrane-associated protein expressed in neurons of the squid and rodent nervous systems , 2002, Neuroscience.

[116]  P. Black,et al.  Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[117]  Nektarios Tavernarakis,et al.  Heritable and inducible genetic interference by double-stranded RNA encoded by transgenes , 2000, Nature Genetics.

[118]  D. J. Jamieson,et al.  The prohibitin family of mitochondrial proteins regulate replicative lifespan , 1997, Current Biology.

[119]  R. Doolittle,et al.  Determining Divergence Times of the Major Kingdoms of Living Organisms with a Protein Clock , 1996, Science.

[120]  M. Reth,et al.  The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin‐related protein. , 1994, The EMBO journal.

[121]  M. Skolnick,et al.  The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. , 1992, Cancer research.

[122]  J. R. Smith,et al.  Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. , 1989, Biochemical and biophysical research communications.

[123]  D. Mann.  Alzheimer's disease and Down's syndrome , 1988, Histopathology.

[124]  J. Steiner,et al.  Enhanced mitochondrial autophagy (mitophagy) in oligodendrocytes might play a role in white matter pathology in schizophrenia. , 2019, Medical hypotheses.

[125]  K. Mohanakumar,et al.  Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson’s Disease , 2016, Molecular Neurobiology.

[126]  Carlos Cepeda,et al.  Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease. , 2012, Journal of Huntington's disease.

[127]  L. Tippett,et al.  Selective neurodegeneration, neuropathology and symptom profiles in Huntington's disease. , 2012, Advances in experimental medicine and biology.

[128]  K. Marinković,et al.  Alcoholism and the Brain: An Overview , 2003, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[129]  M. Dierssen,et al.  Expression patterns of chaperone proteins in cerebral cortex of the fetus with Down syndrome: dysregulation of T-complex protein 1. , 2001, Journal of neural transmission. Supplementum.

[130]  R. Yolken,et al.  Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder , 2000, Molecular Psychiatry.